Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy 23Andme Holding stock

Learn how to easily invest in 23Andme Holding stock.

Our top picks for where to buy 23Andme Holding stock

Best for beginners

Go to site
Commission-free stock trading
  • No-cost financial planning and automated investing
  • $0 commission on stocks, ETFs and options
  • Get up to $1,000 in stock when you fund a new account within 30 days

Top pick for new account bonus

Go to site
$200 in US stocks
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Get $100-$5,000 when you open an account with $5,000 to $1,000,000+

Top pick for interest on uninvested cash

Go to site
Easy access to diverse assets
  • Trade stocks, bonds, options, ETFs, crypto, Treasurys, collectibles, royalties
  • Earn 5.1% APY on your cash
  • Earn a $0.18 rebate on options, with no commissions and no per-contract fees

How to buy 23Andme Holding stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ME. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy 23Andme Holding stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Ratings Available asset types Minimum deposit Stock trade fee Cash sweep APY Signup bonus
SoFi Invest®
Finder Score: 4.1 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Mutual funds, ETFs, Alternatives
$0
$0
Get up to $1,000 in stock
when you fund a new Active Invest account
Tastytrade
Finder Score: 4.6 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $100-$5,000
when you open and fund an account with $5,000 to $1,000,000+
Highly commended for Best Derivatives Trading Platform award.
Public.com
Finder Score: 4.1 / 5: ★★★★★
Public.com
★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
$0
$0
5.1%
N/A
2.5% fee applies to all alternative asset transactions.
Robinhood
Finder Score: 4.3 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
1.5%, or 5% with Robinhood Gold
Get a free stock
when you successfully sign up and link your bank account.
Try Robinhood Gold for 30 days risk-free upon signup and earn a 5% APY on your uninvested cash, a 3% match on IRA contributions, up to $50,000 in instant deposits and more. Accounts are auto-downgraded after the trial period.
Moomoo
Finder Score: 4.7 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
5.10%
Choose a 1.5% match or 7 free fractional shares
when you open a new account and meet funding requirements
No commission stock and ETF trading, with a chance to get a 1.5% cash reward match or 7 free fractional shares.
Cash App
Finder Score: 3 / 5: ★★★★★
Cash App
★★★★★
Stocks, ETFs, Cryptocurrency
$0
$0
4.5%
N/A
Buy and sell over 1,800 stocks and ETFs commission-free and for as little as $1.
Interactive Brokers
Finder Score: 4.3 / 5: ★★★★★
Interactive Brokers
★★★★★
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex, Treasury Bills
$0
$0
3.83% Lite
4.83% Pro
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

AS SEEN ON:

23Andme Holding is a diagnostics & research business based in the US. 23Andme Holding shares (ME) are listed on the NASDAQ and all prices are listed in US Dollars. 23Andme Holding employs 769 staff and has a trailing 12-month revenue of around $248 million.

23Andme Holding stock price (NASDAQ: ME)

Use our graph to track the performance of ME stocks over time.

23Andme Holding shares at a glance

Information last updated 2024-04-17.
Latest market close$0.48
52-week range$0.35 - $2.21
50-day moving average $0.55
200-day moving average $0.95
Wall St. target price$1.43
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.11

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy 23Andme Holding stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

23Andme Holding price performance over time

Historical closes compared with the close of $0.4829 from 2024-04-19

1 week (2024-04-12) 8.96%
1 month (2024-03-20) 2.35%
3 months (2024-01-19) -32.08%
6 months (2023-10-20) -40.97%
1 year (2023-04-20) -76.21%
2 years (2022-04-20) -85.76%
3 years (2021-04-20) 9.9
5 years (2019-04-16) N/A

23Andme Holding financials

Revenue TTM $248 million
Gross profit TTM $132.9 million
Return on assets TTM -26.17%
Return on equity TTM -92.53%
Profit margin -210.48%
Book value $0.78
Market Capitalization $188.4 million

TTM: trailing 12 months

23Andme Holding share dividends

We're not expecting 23Andme Holding to pay a dividend over the next 12 months.

23Andme Holding share price volatility

Over the last 12 months, 23Andme Holding's shares have ranged in value from as little as $0.35 up to $2.21. A popular way to gauge a stock's volatility is its "beta".

ME.US volatility(beta: 1.28)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while 23Andme Holding's is 1.277. This would suggest that 23Andme Holding's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

23Andme Holding overview

23andMe Holding Co. operates as a consumer genetics testing company. The company operates in two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. This segments also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; and offers research services. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to enhance patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing intellectual property associated with identified drug targets related to drug candidates under clinical development. The company's therapeutics product portfolio comprises 23ME-00610 (P006), a humanized monoclonal antibody, which is in phase 1/2a clinical trials to interfere with the ability of CD200R1 to interact with CD200 in cancer cells; and GSK6097608, an antibody that targets CD96 for attenuating T and NK cell anti-tumor immune responses.

Frequently asked questions

What percentage of 23Andme Holding is owned by insiders or institutions?
Currently 3.943% of 23Andme Holding shares are held by insiders and 43.107% by institutions.
How many people work for 23Andme Holding?
Latest data suggests 769 work at 23Andme Holding.
When does the fiscal year end for 23Andme Holding?
23Andme Holding's fiscal year ends in March.
Where is 23Andme Holding based?
23Andme Holding's address is: 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
What is 23Andme Holding's ISIN number?
23Andme Holding's international securities identification number is: US90138Q1085

More guides on Finder

Ask a Question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site